275 related articles for article (PubMed ID: 38331124)
21. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
22. Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Ye Q; Yuan X; Zhou J; Yuan C; Yang X
J Tradit Chin Med; 2017 Apr; 37(2):244-51. PubMed ID: 29960635
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson's disease: a systematic review and meta-analysis.
Zhang G; Xiong N; Zhang Z; Liu L; Huang J; Yang J; Wu J; Lin Z; Wang T
PLoS One; 2015; 10(3):e0118498. PubMed ID: 25756963
[TBL] [Abstract][Full Text] [Related]
24. An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms.
Zhao Q; Bai J; Chen Y; Liu X; Zhao S; Ling G; Jia S; Zhai F; Xiang R
J Ethnopharmacol; 2022 Oct; 297():115567. PubMed ID: 35870684
[TBL] [Abstract][Full Text] [Related]
25. Review of the therapeutic potential of Forsythiae Fructus on the central nervous system: Active ingredients and mechanisms of action.
Zhang L; Lang F; Feng J; Wang J
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117275. PubMed ID: 37797873
[TBL] [Abstract][Full Text] [Related]
26. Medication Rules and Mechanism of Topical Traditional Chinese Medicine for Meibomian Gland Dysfunction-Related Dry Eye Disease.
Zhou H; Wei Q; Yang L; Gao Y
Altern Ther Health Med; 2023 Oct; 29(7):126-132. PubMed ID: 37442185
[TBL] [Abstract][Full Text] [Related]
27. Active ingredients from Chinese medicine plants as therapeutic strategies for asthma: Overview and challenges.
Wang W; Yao Q; Teng F; Cui J; Dong J; Wei Y
Biomed Pharmacother; 2021 May; 137():111383. PubMed ID: 33761604
[TBL] [Abstract][Full Text] [Related]
28. Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway.
Hang W; Fan HJ; Li YR; Xiao Q; Jia L; Song LJ; Gao Y; Jin XM; Xiao BG; Yu JZ; Ma CG; Chai Z
Metab Brain Dis; 2022 Jun; 37(5):1435-1450. PubMed ID: 35488941
[TBL] [Abstract][Full Text] [Related]
29. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer.
Yang Z; Zhang Q; Yu L; Zhu J; Cao Y; Gao X
J Ethnopharmacol; 2021 Jan; 264():113249. PubMed ID: 32810619
[TBL] [Abstract][Full Text] [Related]
30. Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review.
Chang YM; Manoj Kumar M; Lu CY; Te Tsai C; Tsai CC; Liao PH; Lin SL; Chang CC; Mahalakshmi B; Kuo WW; Huang CY
Life Sci; 2020 Sep; 257():118019. PubMed ID: 32629002
[TBL] [Abstract][Full Text] [Related]
31. Glial Nrf2 signaling mediates the neuroprotection exerted by
Lin YE; Lin CH; Ho EP; Ke YC; Petridi S; Elliott CJ; Sheen LY; Chien CT
Elife; 2021 Nov; 10():. PubMed ID: 34779396
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic drug targets and pathways prediction for premature ovarian insufficiency -Based on network pharmacologic method.
Ju S; He J; Wang H; Yang L; Guo A; Guo Y; Qi M; Wang H; Ai L
J Ethnopharmacol; 2023 Mar; 304():116054. PubMed ID: 36526095
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the key active ingredients of 'Radix Astragali and Rehmanniae Radix Mixture' and related signaling pathways involved in ameliorating diabetic foot ulcers from the perspective of TCM-related theories.
Fan S; Shi X; Wang A; Hou T; Li K; Diao Y
J Biomed Inform; 2021 Nov; 123():103904. PubMed ID: 34474187
[TBL] [Abstract][Full Text] [Related]
35. [Study of molecular mechanism of anti-Parkinson's disease traditional Chinese medicine using model of Caenorhabditis elegans].
Wang X; Wang X; Gao H; Wang D
Zhongguo Zhong Yao Za Zhi; 2010 Mar; 35(5):661-3. PubMed ID: 20506834
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of Traditional Chinese medicine/natural medicine in HR-positive Breast Cancer: A comprehensive Literature Review.
Yu Q; Xu C; Song J; Jin Y; Gao X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117322. PubMed ID: 37866466
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of ferroptosis: A new direction in the treatment of ulcerative colitis by traditional Chinese medicine.
Guo M; Du X; Wang X
J Ethnopharmacol; 2024 Apr; 324():117787. PubMed ID: 38253272
[TBL] [Abstract][Full Text] [Related]
38. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
39. [Advance in studies on pathological mechanism of Parkinson's disease and traditional Chinese medicine experiments in prevention and treatment of Parkinson's disease].
Xiong P; Chen X; Zhang N
Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):686-91. PubMed ID: 22693916
[TBL] [Abstract][Full Text] [Related]
40. Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas.
Wang Y; Chen YJ; Xiang C; Jiang GW; Xu YD; Yin LM; Zhou DD; Liu YY; Yang YQ
J Ethnopharmacol; 2020 Apr; 252():112635. PubMed ID: 32004629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
